Se desexas distinguir vos teus produtos, servizos ou ambos os dous doutra empresa, é posible que necesites unha marca ou nome comercial. Descobre que son, en que consiste ou seu procedemento de rexistro e que implica.
Información sobre los plazos de presentación de solicitudes de transformación de marcas de la Unión Europea en marca nacional española. Más información
Se tes un novo dispositivo, produto ou procedemento que resolva un problema técnico ou teña unha vantaxe práctica, existen distintas formas de protexelo en España e noutros países. Descobre como facelo.
A túa innovación reside na estética, a ornamentación ou a aparencia do teu produto? Protéxea mediante un deseño industrial. Descobre que dereitos confire ou rexistro e como realizar a tramitación.
As patentes publicadas en todo ou mundo son unha valiosa fonte de información científica, técnica e comercial.
reembolso del 75% del coste de Búsquedas e Informes Tecnológicos de Patentes. Más información*
Ése emprendedor/a ou unha empresa e queres potenciar e mellorar a rendibilidade do teu negocio protexendo de forma adecuada vos activos intangibles dá túa organización, neste espazo atoparás ou necesario.
154
resultados
Última actualización
27/09/2024 [07:41:00]
Resumen de: WO2024192054A1
A method for monitoring a signal that corresponds to blood glucose level. The method includes transmitting by one or more transmitting (TX) antennas, active RF radio waves below the skin surface of a user, and receiving radio waves on one or more receiving (RX) antennas. The received radio waves include a response portion of the transmitted radio waves. Further, the method includes collecting signals in response to receiving the radio waves on one or more RX antennas; modifying the signals to filter out certain frequencies bands not associated with glucose waveforms; sending the signals to a network processing module; and receiving a blood glucose level from the network processing module in response to the signals.
Resumen de: US2024312590A1
A system for providing dose recommendations of a first and second type of insulin to a user device is described. The system includes a data storage configured to store a medical prescription, measurement values of the blood glucose level, and dose values of the first type of insulin; and one or more processors coupled to the data storage and configured to determine a next dose value of the first type of insulin based on the measurement values, the dose values of the first type of insulin, and dose adjustment rules specified by the prescription: cause a display, on a user interface of the user device, the next dose value of the first type of insulin: determine a next dose value of the second type of insulin based on the dose maintenance rule; and cause a display, on the user interface, the next dose value of the second type of insulin.
Resumen de: WO2024192362A1
Embodiments relate to a control module for storing and accessing insulin delivery parameters to accurately set an insulin dosage amount. The control module can include a processor and a memory having instructions stored thereon that when executed by the processor will cause the processor to: receive glucose data including glucose concentration measurements spanning a time period; identify a minimum glucose concentration measurement (Gmin) within the time period; identify a current glucose concentration measurement (Gc); set an upper bound constraint based on the Gmin and the Gc; generate an adapted insulin dosage schedule by imposing a maximum insulin dosage on an insulin dosage schedule based on the upper bound constraint; and either: administer an insulin dosage in accordance with the adapted insulin dosage schedule; or control administration of insulin via an insulin dosage signal based on the adapted insulin dosage schedule.
Resumen de: AU2024216506A1
A method, system, and device for improving the accuracy of a continuous glucose monitoring sensor by estimating a CGM signal at a time t+PH using a value of 5 CGM at time t, using a real-time short-time glucose prediction horizon to estimate the real time denoised CGM value with a noise estimation algorithm.
Resumen de: AU2024216474A1
Systems and methods are disclosed that employ several or numerous factors in the determination of a glycemic urgency index (GUI), which may be based on a measured blood glucose level as well as other factors. The other factors may include time derivatives of the glucose level and/or other factors, e.g., user - entered data, data measured by other sensors or received from a network source, or historical data. The GUI is then presented to the user in an interesting way, e.g., via a background color or other inconspicuous notifier, e.g., on a mobile device such as a smart phone. The GUI may also be employed in the triggering of actionable alerts and alarms on an electronic device for the user. The GUI, or another index calculated from combinations of the variables and parameters described, may further be employed to drive a medicament delivery device such as a pump.
Resumen de: AU2024216400A1
A stool resuspension solution comprising a hemoglobin stabilization reagent is provided. In some embodiments, the hemoglobin stabilization reagent may be an osmolyte, a polyvalent cation, a sugar or polysaccharide and, optionally, a polyvalent cation, a protoporphyrin,or an HRP stabilization component and, optionally, a polyvalent cation. A method of stabilizing hemoglobin in a stool sample in the solution is also provided, as well as a sample collection device containing the solution.
Resumen de: US2024307618A1
Exemplary embodiments provide an approach to predicting meal and/or exercise events for an insulin delivery system that otherwise does not otherwise identify such events. The insulin delivery system may use a model of glucose insulin interactions that projects estimated future glucose values based on the history of glucose values and insulin deliveries for the user. The predictions of meal events and/or exercise events may be based on residuals between actual glucose values and predicted glucose values. The exemplary embodiments may calculate a rate of change of the residuals over a period of time and compare the rate of change to thresholds to determine whether there likely has been a meal event or an exercise event. The insulin delivery system may then take measures to account for the meal or exercise by the user.
Resumen de: US2024307617A1
One or more embodiments of the disclosure relate, generally, to a diabetes management system. The diabetes management system may include a computing device that is configured to receive data relating to prior insulin use of a user and calculate a sliding scale glucose correction based, at least in part, on the data relating to prior insulin use.
Resumen de: US2024306955A1
The present disclosure relates to a continuous blood sugar measuring device, and provides a continuous blood sugar measuring device which is capable of minimizing additional work of a user in order to attach a body attachment unit, by manufacturing the body attachment unit to be assembled inside an applicator so that the body attachment unit can be attached to the body simply by operating the applicator and, particularly: communicating with an external terminal by providing a wireless communication chip in the body attachment unit so that simple and convenient use is possible and maintenance can easily be performed without the additional work of connecting a separate transmitter; initiating operation by a manipulation of the user, after attaching the body attachment unit to the body, so that an operation initiation time can be adjusted to a suitable time according to the need of the user; and initiating operation in a stabilized state to enable a more accurate measurement of blood sugar.
Resumen de: US2024306950A1
A method for monitoring a signal that corresponds to blood glucose level. The method includes transmitting by one or more transmitting (TX) antennas, active RF radio waves below the skin surface of a user, and receiving radio waves on one or more receiving (RX) antennas. The received radio waves include a response portion of the transmitted radio waves. Further, the method includes collecting signals in response to receiving the radio waves on one or more RX antennas; modifying the signals to filter out certain frequencies bands not associated with glucose waveforms; sending the signals to a network processing module; and receiving a blood glucose level from the network processing module in response to the signals.
Resumen de: US2024306949A1
Digital and graphical user interfaces for multi-analyte monitoring systems are provided. For example, disclosed herein are various embodiments of methods, systems, and interfaces for alarm interfaces, alarm settings interfaces, alarm unavailability interfaces and features, and sensor results interfaces. Various embodiments of interfaces relating to glucose and ketone sensing are disclosed herein.
Resumen de: WO2024191111A1
The present application relates to an AI robot medical hand device which measures, in daily life, the health condition of a subject by means of a bio-sensor provided on a fingertip or a palm of a robot, so as to store and manage same in a storage device on the robot, and which automatically analyzes same by means of artificial intelligence so that risk factors for health of the subject can be identified. Particularly, provided is an AI robot medical hand device and a self-examination method using same, which can simultaneously perform health condition measurement and identity authentication on a subject by means of a bio-sensor provided on a fingertip or a palm of a robot during body contact between a person and the robot in order to check key indicators of health care, such as body heat, blood pressure, blood sugar, electrocardiogram, heat rate, oxygen saturation, cholesterol, and body fat, and thus can prevent disease of the subject in life.
Resumen de: US2024306953A1
The present disclosure relates to a continuous blood sugar measuring device, and provides a continuous blood sugar measuring device which is capable of minimizing additional work of a user in order to attach a body attachment unit, by manufacturing the body attachment unit to be assembled inside an applicator so that the body attachment unit can be attached to the body simply by operating the applicator and, particularly: communicating with an external terminal by providing a wireless communication chip in the body attachment unit so that simple and convenient use is possible and maintenance can easily be performed without the additional work of connecting a separate transmitter; initiating operation by a manipulation of the user, after attaching the body attachment unit to the body, so that an operation initiation time can be adjusted to a suitable time according to the need of the user; and initiating operation in a stabilized state to enable a more accurate measurement of blood sugar.
Resumen de: US2024306951A1
The present disclosure provides a method for monitoring a health parameter of a person in which a system receives data that corresponds to a digital pulse wave signal that is generated from radio frequency data that corresponds to radio waves that have responded from below the skin surface of a person, wherein the radio frequency data is collected through a three-dimensional array of receive antennas, the receive antennas are located at various locations to the transmit antennas, and determines a value that corresponds to a blood glucose level in the person in response to the data that corresponds to the digital pulse wave signal.
Resumen de: US2024307003A1
A method for generating training data for use in monitoring a health parameter of a person in which a waveform database of glucose waveforms and health parameters is created. The device receives a pulse wave signal that is generated from radio frequency scanning data that corresponds to radio waves that have responded from below the skin surface of a person, wherein the radio frequency scanning data is collected through a two-dimensional array of receive antennas over a range of radio frequencies. Then at least one of the pulse wave signals is extracted in response to using convolution matching to the waveform database to generate an extracted signal. Then the data is labeled corresponding to the extracted signal with a corresponding blood glucose level to generate training data.
Resumen de: US2024306954A1
The present disclosure relates to a continuous blood sugar measuring device, and provides a continuous blood sugar measuring device which is capable of minimizing additional work of a user in order to attach a body attachment unit, by manufacturing the body attachment unit to be assembled inside an applicator so that the body attachment unit can be attached to the body simply by operating the applicator and, particularly: communicating with an external terminal by providing a wireless communication chip in the body attachment unit so that simple and convenient use is possible and maintenance can easily be performed without the additional work of connecting a separate transmitter; initiating operation by a manipulation of the user, after attaching the body attachment unit to the body, so that an operation initiation time can be adjusted to a suitable time according to the need of the user; and initiating operation in a stabilized state to enable a more accurate measurement of blood sugar.
Resumen de: US2024307006A1
The technologies discussed herein relate to a biometrics system comprising one or more processors, computer storage memory having computer-executable instructions, surgically implantable devices, and wearables (e.g., an apparel item configured for an upper torso, an apparel item configured for a lower torso, a sock, a headband, other types of wearables, or one or more combinations thereof) having one or more biometric sensors (e.g., a heart rate sensor, a sweat sensor, a glucose sensor, other types of biometric sensors, or one or more combinations thereof) and one or more sensation devices (e.g., a plurality of visible light sources, a haptic feedback device, other types of sensation devices, or one or more combinations thereof). The wearables may also include one or more environmental sensors. The wearables emulate, transmogrify, or enhance one or more human senses using the one or more sensation devices based on biometric data or environmental data received.
Resumen de: US2024312631A1
Techniques and systems include assessing health risk and predicting health events of a patient using measured biosignals. The biosignals may be transformed into a photoplethysmography (PPG) signal or pseudo PPG signal, for example, to measure blood volume changes in the patient's blood flow to derive data indicating a disease state or health-related characteristic, such as blood oxygen level, blood glucose level, heart rate variability, hemoglobin, respiration rate, or arrhythmia. Further, the biosignals can include vocal signals, health labels, and self-reported data related to a patient's health. Assessment and prediction techniques include training an artificial intelligence (AI) model to create embedding vectors based on the measured biosignal(s) that are then ingested by a prediction model to assess and/or predict a patient's health risk and/or health events.
Resumen de: US2024312591A1
The present disclosure relates to systems and methods for controlling physiological glucose concentrations in a patient.
Resumen de: CN118215435A
In some examples, a system for monitoring glucose includes a processing circuit and a glucose monitor including one or more monitoring electrodes and one or more working electrodes wherein a first chemical stack is disposed on at least one of the monitoring electrodes and a second chemical stack is disposed on at least one of the working electrodes. And a second chemical stack disposed on at least one of the working electrodes. The processing circuitry may be configured to measure one or more calibration values of an operating parameter of the monitoring electrode; retrieving one or more pre-calibration values of the operating parameter of the monitoring electrode, wherein the pre-calibration value is measured prior to the calibration value; one or more delta values are determined using the calibration value and the pre-calibration value, and a glucose value sensed by the working electrode is calibrated using the delta values.
Resumen de: US2024298905A1
This invention discloses a method to calculate a HRV profile, including variability and irregularity indexes, and detect the psychophysical condition, atrial fibrillation or ability to control glucose. This method receives data from a QRS detector and wearable non-invasive ECG sensor and starts with the calculation of instantaneous pulses and HRV based on pulses instead of heartbeat intervals, and then calculates the variability and irregularity indexes to detect the psychophysical condition, atrial fibrillation and ability to control the glucose level. The results can be sent to the patient, caregiver and doctor as intelligent message customized to avoid emotional stress and provide a gentle advice for current psychophysical and health condition.
Resumen de: US2024298932A1
Described here are patches and methods for measuring glucose in sweat (and tears and the like). In general, the patches comprise an adhesive layer adapted to bond to skin of an individual, a substrate layer disposed over the adhesive layer and comprising a glucose sensing complex including a chromogen that changes color in the presence of certain concentrations of glucose, and a cover. In typical embodiments, the substrate layer has elements formed to direct and accumulate sweat that migrates from the skin of the individual to the glucose sensing complex. Methods of using the invention can comprise cleaning the skin surface, collecting sweat in a patch comprising this microfluidic constellation of elements, and observing concentrations of glucose collected in the sweat, for example either visually, or by using a smartphone or other computer processing device.
Resumen de: US2024298934A1
A method for detecting and treating lung inflammation. The method includes acquiring a sputum sample from a person suspected to have a lung inflammation, measuring a level of glucose in the sputum sample, detecting lung inflammation status of the person based on the measured level of glucose, and treating the person with a detected lung inflammation by prescribing anti-inflammatory medications to the person based on a clinician's advice. Detecting the lung inflammation status of the person includes detecting no lung inflammation if the measured level of glucose is less than a minimum threshold glucose concentration, or detecting a lung inflammation if the measured level of glucose is equal to or more than a maximum threshold glucose concentration, or detecting a probable lung inflammation if the measured level of glucose is between the minimum threshold glucose concentration and the maximum threshold glucose concentration.
Resumen de: US2024298936A1
Systems and methods are disclosed for non-invasively measuring blood glucose levels in a biological sample based on spectral data. This includes utilizing at least one light source configured to strike a target area of a sample, utilizing at least one light filter positioned to receive light transmitted through the target area from the at least one light source, utilizing at least one light detector positioned to receive light from the at least one light source and filtered by the at least one light filter, and to generate an output signal, having a time dependent current, which is indicative of the power of light detected, receiving the output signal from the at least one light detector with a processor and based on the received output signal, calculating the attenuance attributable to blood in a sample with a signal-to-noise ratio of at least 20-to-1; and determining a blood glucose level.
Nº publicación: US2024298941A1 12/09/2024
Solicitante:
MEDTRONIC MINIMED INC [US]
Medtronic MiniMed, Inc
Resumen de: US2024298941A1
Embodiments of the invention provide amperometric analyte sensors having optimized elements such as interference rejection membranes, and associated architectures, as well as methods for making and using such sensors. While embodiments of the innovation can be used in a variety of contexts, typical embodiments of the invention include glucose sensors used in the management of diabetes.
BOPI
Sede Electrónica
